Riverside Company invests in MDoutlook
The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in MDoutlook, a provider of precision intelligence solutions that help life sciences companies develop and commercialise therapeutics and diagnostics in oncology. This is an add-on to Riverside’s Clinical Education Alliance, LLC (CEA)